Company Reports

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.

Fairfax has been generating good underwriting results recently, a trend that continued in the second quarter. On the investment side, the company saw a substantial gain on its equity investments.

Fairfax's first-quarter results were mixed, with a reasonable showing on the underwriting side offset by some investment losses.

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.

Fairfax Financial capped off a very strong year with good results in the fourth quarter, as it continues to ride tailwinds on both sides of its business.

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. As a result, compared with other insurers, the company's results tend to be much more driven by results on the investment side. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.

Like its peers, Fairfax produced a strong third quarter. Industry tailwinds on both the underwriting and investment side remain in place for now, with low catastrophe losses providing a further boost.

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. As a result, compared with other insurers, the company's results tend to be much more driven by results on the investment side. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.

Fairfax reported a strong quarter, as the company continues to benefit from tailwinds on both sides of its business, with stronger equity markets as an additional boost.

Fairfax's reported results were negatively affected by $692 million in losses from the California wildfires, but that was more than offset by $1.1 billion in investment gains.

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chair and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. As a result, compared with other insurers, the company's results tend to be much more driven by results on the investment side. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.

Like its peers, Fairfax is enjoying multiple tailwinds at the moment that are driving strong performance. For the full year, book value per share, adjusted for dividends, grew 14.5%. We will maintain our CAD 1,290 fair value estimate for the no-moat company and see shares as materially overvalued. We think the market is overly focused on the positive near-term picture for Fairfax and its P&C insurance peers and not fully factoring in the fact that returns will ultimately normalize. We think this is especially true for Fairfax, given that it has had some additional positives recently.

Fairfax’s third-quarter results were positively impacted by a $1.3 billion gain on investments, which drove net income of $1.0 billion for the quarter. But even putting this aside, results looked strong. Fairfax, like its peers, is currently enjoying tailwinds on both sides of the business as underwriting conditions remain favorable and higher interest rates boost investment income. Adjusted for dividends, book value per share has increased 12% since the end of 2023. We will maintain our fair value estimate for the no-moat company and see the shares as materially overvalued. We believe the market is overly focused on near-term results, and we expect returns to normalize over time.

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chairman and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. As a result, compared with other insurers, the company's results tend to be driven more by results on the investment side. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers. Fairfax's underwriting record is relatively poor, although it has improved recently.

Fairfax enjoyed a strong second quarter, as it is benefiting from favorable industry underwriting conditions and seeing some tailwinds on the investment side. Book value per share, adjusted for dividends, is up 6% from year-end. We think the near-term outlook for the company is bright, but we also believe that insurance is a highly competitive and inherently mean-reverting industry, and that current tailwinds will dissipate. We will maintain our CAD 1,180 fair value estimate for the no-moat company. We see shares as overvalued and think the market is overly focused on the company’s near-term prospects.

We think Fairfax’s first-quarter results were solid. Underwriting margins held at an attractive level, and tailwinds continue on the investing side. Book value per share, adjusted for dividends, increased 2% from year-end. We will maintain our CAD 1,180 fair value estimate and no-moat rating. We continue to see shares as overvalued. While Fairfax is performing well right now, its historical record is mixed, and we think the market is overly focused on the favorable near-term outlook.

We are increasing our fair value estimate for Fairfax to CAD 1,180 per share from CAD 970 after reassessing the company's prospects on the investment side given recent changes in capital market conditions. Our fair value estimate equates to 1.0 times year-end 2023 book value and 1.4 times tangible book value. We still see the shares as materially overvalued from a long-term perspective. While the company is navigating the current capital market environment well, we would note that Fairfax's investment performance has been spotty over time. Although the company is riding high at the moment, its historical track record includes some substantial losses along with impressive gains.

While its primary business is insurance, Fairfax is in some ways more of an investment fund. Chairman and CEO Prem Watsa has a long history of bold investment bets and has shown a willingness to be unorthodox when it comes to portfolio construction. As a result, compared with other insurers, the company's results tend to be driven more by results on the investment side. We're somewhat skeptical of this approach, as we believe disciplined underwriting is a more reliable path to long-term value creation for insurers, and Fairfax's underwriting record is relatively poor.

Fairfax finished the year on a strong note and continues to benefit from industry and macroeconomic tailwinds. Book value per share, adjusted for dividends, increased 25% for the full year, a metric that we believe highlights how favorable the environment has been for the no-moat company. We are maintaining our CAD 970 per share fair value estimate and see the shares as overvalued right now. We think the current market is overly tied to the positive near-term outlook, and we retain concerns about Fairfax's future given its up-and-down historical performance.

Short-seller Muddy Waters released a report outlining a bear case on no-moat Fairfax. At a high level, we don’t disagree with its take, and we do think the stock is materially overvalued right now. In our opinion, Fairfax is a hit-and-miss investor, a relatively poor underwriter, and has an overly complicated structure. We would agree that the company’s book value growth target of 15% is unrealistic, and it has generally fallen well short of this level since the financial crisis. As to Muddy Waters' claims that Fairfax is mismarking investments, we don’t think it is necessary to believe that to think the stock is overvalued. We will maintain our CAD 970 fair value estimate.